cabergoline
Generic: cabergoline
Labeler: ingenus pharmaceuticals, llcDrug Facts
Product Profile
Brand Name
cabergoline
Generic Name
cabergoline
Labeler
ingenus pharmaceuticals, llc
Dosage Form
TABLET
Routes
Active Ingredients
cabergoline .5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
50742-118
Product ID
50742-118_9bcb5111-ddb4-46f6-9318-e4a9d51d9e30
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA204735
Listing Expiration
2026-12-31
Marketing Start
2018-08-09
Pharmacologic Class
Established (EPC)
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
50742118
Hyphenated Format
50742-118
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
cabergoline (source: ndc)
Generic Name
cabergoline (source: ndc)
Application Number
ANDA204735 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .5 mg/1
Packaging
- 8 TABLET in 1 BOTTLE (50742-118-08)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "9bcb5111-ddb4-46f6-9318-e4a9d51d9e30", "openfda": {"nui": ["M0007652", "N0000175827"], "upc": ["0350742118083"], "unii": ["LL60K9J05T"], "rxcui": ["199703"], "spl_set_id": ["57cbd81e-fdb9-4060-80ee-6e8581c463a4"], "pharm_class_cs": ["Ergolines [CS]"], "pharm_class_epc": ["Ergot Derivative [EPC]"], "manufacturer_name": ["Ingenus Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "8 TABLET in 1 BOTTLE (50742-118-08)", "package_ndc": "50742-118-08", "marketing_start_date": "20180809"}], "brand_name": "Cabergoline", "product_id": "50742-118_9bcb5111-ddb4-46f6-9318-e4a9d51d9e30", "dosage_form": "TABLET", "pharm_class": ["Ergolines [CS]", "Ergot Derivative [EPC]"], "product_ndc": "50742-118", "generic_name": "Cabergoline", "labeler_name": "Ingenus Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cabergoline", "active_ingredients": [{"name": "CABERGOLINE", "strength": ".5 mg/1"}], "application_number": "ANDA204735", "marketing_category": "ANDA", "marketing_start_date": "20180809", "listing_expiration_date": "20261231"}